Related Experiment Video
Updated: May 10, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
Pouya Azar1,2, Jessica Machado1, Jane J Kim3,4
1Complex Pain and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.
Background:
Buprenorphine is a common partial opioid agonist treatment for opioid use disorder (OUD). Despite its efficacy, major challenges to induction include the significant time consumption and the difficult requirement for patients to be in moderate opioid withdrawal.
Case Presentation:
We present the case of a 31-year-old man with severe OUD and regular fentanyl use who was successfully initiated on buprenorphine-naloxone using low-dose intravenous naloxone in ten minutes and administered 300 mg of extended-release injectable buprenorphine within two hours. This involved the rapid administration of small doses of intravenous naloxone with an assessment of withdrawal symptoms after each dose. Buprenorphine-naloxone is immediately administered once moderate withdrawal is reached.
Conclusions:
Low-dose intravenous naloxone provides an alternative method of buprenorphine induction that limits the experience of withdrawal to a shorter time window compared to existing protocols.
More Related Videos
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
Pharmaceutical Poisoning: Treatment Strategies

